From TECHNOLOGY 11:57pm

GSK flu vaccine linked to sleep disorder

Scientists find risk of narcolepsy increased

From INDUSTRIALS 10:37pm

Croda cites niche products for sales lift

Speciality chemicals producer banks on consumer care division

Feb 25, 2013

Almirall wary over need to issue shares

Gallardo determined to maintain family’s controlling stake

From FINANCIALS Feb 25, 2013

Ireland ripe for M&A surge, says report

Potential deals highlighted in pharmaceutical and medical sectors

Feb 25, 2013

Royalty makes bid to take over Elan

Private equity group in move to gain access to drug income

Lombard Feb 25, 2013

Return of bear hug would show M&A revival

Royalty Pharma’s bid for Elan is well below a killer price

From LEX Feb 25, 2013

Reckitt Benckiser: motorcycle maintenance

The pharma side is proving a creaky sidecar

Feb 25, 2013

Reckitt Benckiser hit by generic ruling

Rival versions of highly profitable Suboxone get green light

Feb 25, 2013

Genus plans further China expansion

Animal genetics group eyes joint ventures in pork farming

From LEX Feb 25, 2013

Elan / Royalty Pharma: gone shopping

Which investment banker-turned-pharma executive will investors back?

Feb 24, 2013

Novartis’ U-turn marks a crossroads

Retirement package for Vasella raises investor scrutiny over pay

Feb 23, 2013

Elan unveils share $1bn buyback

Drug group’s plan includes move to seek fresh acquisitions

From MARKETS Feb 23, 2013

Phytopharm falls after drug test failure

Trial for Parkinson’s treatment shows drug has no effects

Feb 22, 2013

Vasella admits mistakes over $78m payout

Shareholders not appeased by Novartis chairman’s concession

From WORLD Feb 20, 2013

Pryce faces retrial after jury discharged

Circumstances of case raise questions about jury system

From TECHNOLOGY Feb 20, 2013

Winners of life science prize revealed

Silicon Valley billionaires pledge $50m

Feb 19, 2013

Novartis pay criticism unlikely to abate

The group is still likely to face an uncomfortable grilling, write James Shotter and Andrew Jack

John Gapper Feb 19, 2013

Novartis and the flaw in paying for executive loyalty

Feb 19, 2013

Novartis scraps chairman’s $78m payout

Shareholder anger forces U-turn on Vasella

Feb 18, 2013

Phytopharm’s Parkinson’s drug flops

Drug fails to show any benefits

MOST POPULAR NOW ON FT.COM

COMPANIES NEWS ON TWITTER

More FT Twitter accounts